Dohl J, Treadwell Z, Norris C, Head E
Alzheimers Dement. 2025; 21(3):e70034.
PMID: 40042516
PMC: 11881635.
DOI: 10.1002/alz.70034.
Brown M, Sciascia E, Ning K, Adam W, Veraksa A
G3 (Bethesda). 2024; 14(11).
PMID: 39271109
PMC: 11540318.
DOI: 10.1093/g3journal/jkae219.
Chowdhury M, Haq M, Lee J, Jeong S
Front Mol Neurosci. 2024; 17:1408949.
PMID: 39165717
PMC: 11333461.
DOI: 10.3389/fnmol.2024.1408949.
Murphy A, Wilton S, Aung-Htut M, McIntosh C
Front Mol Neurosci. 2024; 17:1391564.
PMID: 39114642
PMC: 11303307.
DOI: 10.3389/fnmol.2024.1391564.
Shen M, Zhang Y, Wu F, Shen M, Liang J, Zhang X
World J Gastrointest Oncol. 2024; 16(4):1453-1464.
PMID: 38660649
PMC: 11037043.
DOI: 10.4251/wjgo.v16.i4.1453.
Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer's Disease.
Warren H, Saeger H, Tombari R, Chytil M, Rasmussen K, Olson D
J Med Chem. 2024; 67(9):6922-6937.
PMID: 38648167
PMC: 11152242.
DOI: 10.1021/acs.jmedchem.3c01696.
GR/Ahi1 regulates WDR68-DYRK1A binding and mediates cognitive impairment in prenatally stressed offspring.
Wei B, Shi H, Yu X, Shi Y, Zeng H, Zhao Y
Cell Mol Life Sci. 2024; 81(1):20.
PMID: 38195774
PMC: 11073104.
DOI: 10.1007/s00018-023-05075-1.
Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model.
Hawley L, Stringer M, Deal A, Folz A, Goodlett C, Roper R
Neurobiol Dis. 2023; 190:106359.
PMID: 37992782
PMC: 10843801.
DOI: 10.1016/j.nbd.2023.106359.
Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A.
Ananthapadmanabhan V, Shows K, Dickinson A, Litovchick L
Front Cell Dev Biol. 2023; 11:1277537.
PMID: 37900285
PMC: 10600473.
DOI: 10.3389/fcell.2023.1277537.
Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders.
Hogg E, Findlay G
FEBS Lett. 2023; 597(19):2375-2415.
PMID: 37607329
PMC: 10952393.
DOI: 10.1002/1873-3468.14723.
Over-expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice.
Postic G, Solarz J, Loubiere C, Kandiah J, Sawmynaden J, Adam F
J Cell Mol Med. 2023; 27(15):2228-2238.
PMID: 37415307
PMC: 10399536.
DOI: 10.1111/jcmm.17817.
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
Strine M, Cai W, Wei J, Alfajaro M, Filler R, Biering S
PLoS Biol. 2023; 21(6):e3002097.
PMID: 37310920
PMC: 10263356.
DOI: 10.1371/journal.pbio.3002097.
The Conserved Transcriptional Activation Activity Identified in Dual-Specificity Tyrosine-(Y)-Phosphorylation-Regulated Kinase 1.
Ouyang X, Wang Z, Wu B, Yang X, Dong B
Biomolecules. 2023; 13(2).
PMID: 36830653
PMC: 9953678.
DOI: 10.3390/biom13020283.
Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer's disease: An integrative molecular modeling approach.
Shukla R, Kumar A, Kelvin D, Singh T
Front Mol Biosci. 2023; 9:1078987.
PMID: 36741918
PMC: 9892649.
DOI: 10.3389/fmolb.2022.1078987.
Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
Hamze R, Delangre E, Tolu S, Moreau M, Janel N, Bailbe D
Int J Mol Sci. 2022; 23(23).
PMID: 36499613
PMC: 9739879.
DOI: 10.3390/ijms232315287.
Impaired macroglial development and axonal conductivity contributes to the neuropathology of DYRK1A-related intellectual disability syndrome.
Pijuan I, Balducci E, Soto-Sanchez C, Fernandez E, Barallobre M, Arbones M
Sci Rep. 2022; 12(1):19912.
PMID: 36402907
PMC: 9675854.
DOI: 10.1038/s41598-022-24284-5.
Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits.
Afzal O, Dalhat M, Altamimi A, Rasool R, Alzarea S, Almalki W
Molecules. 2022; 27(21).
PMID: 36364431
PMC: 9655201.
DOI: 10.3390/molecules27217604.
The Omnipresence of DYRK1A in Human Diseases.
Deboever E, Fistrovich A, Hulme C, Dunckley T
Int J Mol Sci. 2022; 23(16).
PMID: 36012629
PMC: 9408930.
DOI: 10.3390/ijms23169355.
Local mRNA translation and cytoskeletal reorganization: Mechanisms that tune neuronal responses.
Triantopoulou N, Vidaki M
Front Mol Neurosci. 2022; 15:949096.
PMID: 35979146
PMC: 9376447.
DOI: 10.3389/fnmol.2022.949096.
DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients.
Moreau M, Carmona-Iragui M, Altuna M, Dalzon L, Barroeta I, Vilaire M
Biomedicines. 2022; 10(6).
PMID: 35740400
PMC: 9219646.
DOI: 10.3390/biomedicines10061380.